Clinical Trial Update: The Role of Dexmedetomidine as Myocardial Protector in Pediatric Cardiac Surgery Total Correction of Tetralogy of Fallot [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial investigating dexmedetomidine as a myocardial protector in pediatric cardiac surgery for total correction of Tetralogy of Fallot; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease in Children
• Tetralogy of Fallot

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia | Conditions: Congenital Heart Disease in Children, Cardiopulmonary Bypass | Phase 2, Phase 3 | Status: COMPLETED